Hughes, T. P., Hochhaus, A., Branford, S., Müller, M. C., Kaeda, J. S., Foroni, L., . . . Radich, J. P. (2010). Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: An analysis from the International Randomized Study of Interferon and STI571 (IRIS). American Society of Hematology.
Chicago Style citaatHughes, Timothy P., et al. Long-term Prognostic Significance of Early Molecular Response to Imatinib in Newly Diagnosed Chronic Myeloid Leukemia: An Analysis From the International Randomized Study of Interferon and STI571 (IRIS). American Society of Hematology, 2010.
MLA citatieHughes, Timothy P., et al. Long-term Prognostic Significance of Early Molecular Response to Imatinib in Newly Diagnosed Chronic Myeloid Leukemia: An Analysis From the International Randomized Study of Interferon and STI571 (IRIS). American Society of Hematology, 2010.